Advertisement
Screener

Titan Pharmaceuticals, Inc. Royalty Expense

Titan Pharmaceuticals, Inc. Royalty Expense

Titan Pharmaceuticals, Inc. reported Royalty Expense of $40.00 million for the 1-month period ending 2011-03-15, per its 10-K filed 2015-03-31.

Discontinued › Expense Statement › Operating Expenses

us-gaap:RoyaltyExpense · last filed 2015-03-31

  • 2011-03-15: Royalty Expense 0 month $40.00M; Royalty Expense 1 month $40.00M.
Period endRoyalty Expense 0 monthRoyalty Expense 1 month
2011-03-15$40.00M
10-K · filed 2014-03-31
$40.00M
10-K · filed 2015-03-31